Medicamen Biotech Q2 Results
- BSE: 531146
- NSE: MEDICAMEQ
- ISIN: INE646B01010
- Sector: Biotechnology & Drugs
BSE
442.7
-5.35 (-1.19%)
-5.35 (-1.19%)Volume1.24 K
Updated: Mon 25 Nov, 2024 | 15:28:51
NSE
435.1-11.65 (-2.61%)
-11.65 (-2.61%)Volume23.85 K
Updated: Mon 25 Nov, 2024 | 15:29:47
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹44.74 Cr.(3.94%)
- Operating Profit₹2.71 Cr.(61.59%)
- Profit After Tax₹1.46 Cr.(7.79%)
- Operating Margin6.05%(-35.99%)
Note: Comparison is on YoY basis
Quarterly - Medicamen Biotech Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 24 | Jun 23 | QoQ Comp | Sep 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Revenue | 44.74 | 41.94 | -% | 85.48 | -% |
| Selling/ General/ Admin Expenses Total | 7.63 | 6.56 | -% | 13.66 | -% |
| Depreciation/ Amortization | 2.61 | 1.69 | -% | 3.51 | -% |
| Other Operating Expenses Total | 7.35 | 7.56 | -% | 16.21 | -% |
| Total Operating Expense | 42.04 | 36.68 | -% | 77.40 | -% |
| Operating Income | 2.71 | 5.26 | -% | 8.08 | -% |
| Net Income Before Taxes | 1.96 | 4.68 | -% | 7.15 | -% |
| Net Income | 1.46 | 4.18 | -% | 6.77 | -% |
| Diluted Normalized EPS | 1.15 | 3.12 | -% | 4.90 | -% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
- Markets
01NTPC Green Energy IPO allotment date likely today. GMP, how to check status online
2 min read07:58 AM IST - Markets
02Buy or sell: Sumeet Bagadia recommends three stocks to buy on Monday — Nov 25
4 min read06:15 AM IST - Markets
03Enviro Infra Engineers IPO day 2: GMP jumps; subscription status, review, apply or not?
3 min read03:07 PM IST